Ground Hemlock - A New Source for an Anti-Cancer Drug
A New Forest Product used to
Fight Cancer
Researchers at the Canadian Forest Service’s Atlantic Forestry Centre (CFS-AFC) are working with partners from provincial governments, universities, ENGO’s and the private sector in the fight against cancer. The goal is to develop a new forest-based industry in eastern Canada using ground hemlock.
What is Ground Hemlock?
Ground hemlock (Taxus canadensis), also known as eastern yew, is a small, spreading, evergreen shrub found in many woodlots and shaded areas. It’s needles and bark contain paclitaxel, the active ingredient used in the anti-cancer drug Taxol®. Paclitaxel as well as other closely related compounds called taxanes, are used to fight more than 20 cancerous and non-cancerous diseases.
Who is involved?
Atlantic Forestry Centre researchers are leading a multi-discipline, multi-partner program to promote the development of a new forest-based industry producing the anti-cancer drug Taxol®. CFS-AFC was instrumental in bringing together representatives from six eastern Canadian provinces, the private sector (commercial harvesters and processors), the University of New Brunswick, and Falls Brook Centre (an environmental non-government organization) to form the Eastern Canadian Ground Hemlock Working Group.
Researchers at the Canadian Forest Service’s Atlantic Forestry Centre (CFS-AFC) are working with partners from provincial governments, universities, ENGO’s and the private sector in the fight against cancer. The goal is to develop a new forest-based industry in eastern Canada using ground hemlock.
What is Ground Hemlock?
Ground hemlock (Taxus canadensis), also known as eastern yew, is a small, spreading, evergreen shrub found in many woodlots and shaded areas. It’s needles and bark contain paclitaxel, the active ingredient used in the anti-cancer drug Taxol®. Paclitaxel as well as other closely related compounds called taxanes, are used to fight more than 20 cancerous and non-cancerous diseases.
Who is involved?
Atlantic Forestry Centre researchers are leading a multi-discipline, multi-partner program to promote the development of a new forest-based industry producing the anti-cancer drug Taxol®. CFS-AFC was instrumental in bringing together representatives from six eastern Canadian provinces, the private sector (commercial harvesters and processors), the University of New Brunswick, and Falls Brook Centre (an environmental non-government organization) to form the Eastern Canadian Ground Hemlock Working Group.

